Early administration of ritonavir-boosted lopinavir could prevent severe COVID-19
| Errataetall: |
CommentOn: Lancet. 2003 May 24;361(9371):1767-72. - PMID 12781535 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:82 |
|---|---|
| Enthalten in: |
The Journal of infection - 82(2021), 1 vom: 01. Jan., Seite 159-198 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Klement-Frutos, Elise [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
2494G1JF75 |
|---|
| Anmerkungen: |
Date Completed 27.01.2021 Date Revised 18.05.2021 published: Print-Electronic CommentOn: Lancet. 2003 May 24;361(9371):1767-72. - PMID 12781535 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jinf.2020.05.039 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM310536855 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM310536855 | ||
| 003 | DE-627 | ||
| 005 | 20231225140318.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jinf.2020.05.039 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1035.xml |
| 035 | |a (DE-627)NLM310536855 | ||
| 035 | |a (NLM)32473230 | ||
| 035 | |a (PII)S0163-4453(20)30318-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Klement-Frutos, Elise |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Early administration of ritonavir-boosted lopinavir could prevent severe COVID-19 |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 27.01.2021 | ||
| 500 | |a Date Revised 18.05.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Lancet. 2003 May 24;361(9371):1767-72. - PMID 12781535 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 4 | |a Covid-19 | |
| 650 | 4 | |a Lopinavir | |
| 650 | 4 | |a Protease inhibitor | |
| 650 | 4 | |a Sars-cov-2 | |
| 650 | 4 | |a Virology | |
| 650 | 4 | |a pharmacology | |
| 650 | 7 | |a Antiviral Agents |2 NLM | |
| 650 | 7 | |a Lopinavir |2 NLM | |
| 650 | 7 | |a 2494G1JF75 |2 NLM | |
| 650 | 7 | |a Ritonavir |2 NLM | |
| 650 | 7 | |a O3J8G9O825 |2 NLM | |
| 700 | 1 | |a Burrel, Sonia |e verfasserin |4 aut | |
| 700 | 1 | |a Peytavin, Gilles |e verfasserin |4 aut | |
| 700 | 1 | |a Marot, Stéphane |e verfasserin |4 aut | |
| 700 | 1 | |a Lê, Minh P |e verfasserin |4 aut | |
| 700 | 1 | |a Godefroy, Nagisa |e verfasserin |4 aut | |
| 700 | 1 | |a Calvez, Vincent |e verfasserin |4 aut | |
| 700 | 1 | |a Marcelin, Anne-Geneviève |e verfasserin |4 aut | |
| 700 | 1 | |a Caumes, Eric |e verfasserin |4 aut | |
| 700 | 1 | |a Pourcher, Valérie |e verfasserin |4 aut | |
| 700 | 1 | |a Boutolleau, David |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of infection |d 1982 |g 82(2021), 1 vom: 01. Jan., Seite 159-198 |w (DE-627)NLM012791822 |x 1532-2742 |7 nnns |
| 773 | 1 | 8 | |g volume:82 |g year:2021 |g number:1 |g day:01 |g month:01 |g pages:159-198 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jinf.2020.05.039 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 82 |j 2021 |e 1 |b 01 |c 01 |h 159-198 | ||